SLAP HIV program is funded by the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and consists of several teams (sections) that work together toward the goal of developing and testing in Phase I clinical trial the most promising long-acting antiretroviral delivery system to prevent HIV.